To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Butorphanol as an Adjuvant to Ropivacaine for Adductor Canal Blocks in Total Knee Arthroplasty

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
December 2022

Butorphanol as an Adjuvant to Ropivacaine for Adductor Canal Blocks in Total Knee Arthroplasty

Vol: 302| Issue: 4| Number:15| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Butorphanol as an Adjuvant to Ropivacaine for Adductor Canal Blocks in Total Knee Arthroplasty Patients: A Randomized, Double, Blind Study

J Healthc Eng. 2022 Oct 14;2022:7718108.

Contributing Authors:
T Mu D Liu F Gao

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Seventy-four older patients (50-80 years) undergoing a first-time unilateral total knee arthroplasty were randomized to receive an adductor canal blockade with ropivacaine plus butorphanol as an adjuvant (n=37) or ropivacaine only (n=37). The primary outcome of interest was the duration of sensory block and Visual Analog Scale (VAS) pain scores at rest and with activity. Secondary outcomes of inte...

Join the Conversation

Please Login or Join to leave comments.